Experiment 694283
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | KUCUK,O: YOUNG,ML: HABERMANN,TM: WOLF,BC: JIMENO,J: CASSILETH,PA:. (2000). PHASE II TRIAL OF DIDEMNIN B IN PREVIOUSLY TREATED NON-HODGKIN'S LYMPHOMA. AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) STUDY.. 23(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | 29 ELIGIBLE IG/HG PATIENTS, 20 WERE FEMALE AND 9 MALE, WITH A MEDIAN AGE OF 65 YEARS (37-84). 22 ELIGIBLE LP PATIENTS, 11 WERE FEMALE AND 11 MALE, WITH A MEDIAN AGE OF 65 YEARS (29-76); PATIENTS WITH NON-HODGKIN'S LYMPHOMA. |
| Dose amount | 5.6 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |